Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

Men with sexual side effects from finasteride may face higher risks of depression and suicidal thoughts.

Participating in Sexual Orientation Change Efforts may increase the risk of suicide for sexual minority individuals.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Finasteride use in young people may increase risk of suicidal thoughts and mental health issues.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Finasteride can double the risk of sexual problems like ejaculation issues, low libido, and impotence.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.